Núria Viñolas

7.2k total citations
123 papers, 4.3k citations indexed

About

Núria Viñolas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Núria Viñolas has authored 123 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 59 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Núria Viñolas's work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (29 papers) and Lung Cancer Diagnosis and Treatment (27 papers). Núria Viñolas is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (29 papers) and Lung Cancer Diagnosis and Treatment (27 papers). Núria Viñolas collaborates with scholars based in Spain, United States and France. Núria Viñolas's co-authors include C Rozmán, Ramón M. Marrades, Emilio Montserrat, Alfons Navarro, Mariano Monzó, Francesc Graus, Laureano Molins, José Ramírez, Rafael Rosell and E. Verger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Núria Viñolas

121 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Núria Viñolas Spain 33 1.6k 1.5k 1.5k 1.2k 1.0k 123 4.3k
José A. Martínez-Climent Spain 39 1.9k 1.2× 1.3k 0.9× 483 0.3× 784 0.6× 865 0.8× 135 4.5k
Benjamin Esterni France 32 1.4k 0.9× 2.2k 1.5× 683 0.5× 1.0k 0.8× 422 0.4× 75 4.4k
Peter Langmuir United States 30 1.3k 0.8× 1.8k 1.2× 1.6k 1.1× 507 0.4× 384 0.4× 56 4.7k
Ming‐Tseh Lin United States 30 897 0.6× 1.2k 0.8× 853 0.6× 736 0.6× 354 0.3× 76 3.3k
Morten Mau‐Sørensen Denmark 28 1.1k 0.7× 1.2k 0.8× 527 0.4× 541 0.4× 570 0.6× 130 2.7k
Thierry Lesimple France 32 1.2k 0.7× 2.0k 1.3× 1.0k 0.7× 401 0.3× 459 0.4× 139 3.3k
Raoul Tibes United States 34 3.6k 2.2× 1.5k 1.0× 418 0.3× 576 0.5× 771 0.7× 144 5.3k
J. Thaddeus Beck United States 29 1.3k 0.8× 2.6k 1.7× 1.3k 0.9× 623 0.5× 307 0.3× 113 3.7k
Tahseen Al‐Saleem United States 34 1.5k 0.9× 984 0.6× 1.6k 1.1× 645 0.5× 225 0.2× 119 3.7k
J Garcı́a-Conde Spain 35 954 0.6× 2.0k 1.4× 425 0.3× 584 0.5× 792 0.8× 104 3.9k

Countries citing papers authored by Núria Viñolas

Since Specialization
Citations

This map shows the geographic impact of Núria Viñolas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Viñolas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Viñolas more than expected).

Fields of papers citing papers by Núria Viñolas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Viñolas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Viñolas. The network helps show where Núria Viñolas may publish in the future.

Co-authorship network of co-authors of Núria Viñolas

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Viñolas. A scholar is included among the top collaborators of Núria Viñolas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Viñolas. Núria Viñolas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epaillard, Nicolas, José Carlos Benítez, Elizabeth Fabre, et al.. (2021). Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study. Lung Cancer. 155. 114–119. 12 indexed citations
2.
Fuster, David, et al.. (2021). Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3631–3642. 6 indexed citations
3.
Benegas, Mariana, Núria Viñolas, Roxana Reyes, et al.. (2021). A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC. Cancers. 13(21). 5566–5566. 3 indexed citations
4.
Auclin, Édouard, Roxana Reyes, Cristina Teixidó, et al.. (2021). P09.15 Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19. Journal of Thoracic Oncology. 16(3). S294–S295. 1 indexed citations
5.
Victoria, Iván, Pedro Jares, Núria Viñolas, et al.. (2021). Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice. Journal of Thoracic Disease. 13(3). 1658–1670. 5 indexed citations
6.
Reyes, Roxana, Rafael López Castro, Édouard Auclin, et al.. (2021). MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer. Journal of Thoracic Oncology. 16(3). S141–S141. 21 indexed citations
7.
Castellano, Joan J., Ramón M. Marrades, Laureano Molins, et al.. (2020). Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior. Cancers. 12(3). 734–734. 41 indexed citations
8.
Teixidó, Cristina, Ramón M. Marrades, Núria Viñolas, et al.. (2019). EP1.01-41 Feasibility of EBUS-TBNA Cytologies for an Extensive Assessment of Predictive Biomarkers in Lung Cancer. Journal of Thoracic Oncology. 14(10). S927–S928. 1 indexed citations
9.
Aguado, Carlos, Manuel Dómine, Antonio Calles, et al.. (2018). 159P Clinical activity of afatinib in a cohort of patients with lung adenocarcinoma harbouring uncommon EGFR mutations: A Spanish retrospective multicentre study. Journal of Thoracic Oncology. 13(4). S95–S96. 1 indexed citations
10.
Prat, Aleix, Alejandro Navarro, Laia Paré, et al.. (2017). Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma. Cancer Research. 77(13). 3540–3550. 277 indexed citations
11.
Remón, Jordi, Dolores Isla, Pilar Garrido, et al.. (2017). Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database. Clinical & Translational Oncology. 19(12). 1537–1542. 4 indexed citations
12.
Schmid‐Bindert, Gerald, Walburga Engel-Riedel, Martin Reck, et al.. (2015). A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Lung Cancer. 90(3). 397–404. 9 indexed citations
13.
Molina, Rafael, Ramón M. Marrades, Josep M. Augé, et al.. (2015). Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 193(4). 427–437. 131 indexed citations
14.
Campayo, Marc, Alfons Navarro, Núria Viñolas, et al.. (2012). Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. European Respiratory Journal. 41(5). 1172–1178. 64 indexed citations
15.
Campayo, Marc, Núria Viñolas, Alfons Navarro, et al.. (2011). Single Nucleotide Polymorphisms in Tobacco Metabolism and DNA Repair Genes and Prognosis in Resected Non-Small-Cell Lung Cancer. Journal of Surgical Research. 167(1). e5–e12. 6 indexed citations
16.
17.
Pera, Manuel, et al.. (2001). Metastatic Carcinoma of the Breast Resembling Early Gastric Carcinoma. Mayo Clinic Proceedings. 76(2). 205–207. 18 indexed citations
18.
Agustı́, Carles, Juan J. Grau, Michael J. Daniels, et al.. (1992). Chronic oral etoposide in non-small cell lung carcinoma. European Journal of Cancer. 28(4-5). 835–837. 15 indexed citations
19.
Rozmán, C, Dolors Colomer, Ignacio Anegón, et al.. (1988). Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B‐chronic lymphocytic leukemia. American Journal of Hematology. 27(3). 157–162. 13 indexed citations
20.
Doménech, Pedro, et al.. (1986). Severe Aplastic Anaemia following Hepatitis A. Acta Haematologica. 76(4). 227–229. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José A. Martínez-Climent Breakdown of academic impact, for papers by Benjamin Esterni Breakdown of academic impact, for papers by Peter Langmuir Breakdown of academic impact, for papers by Ming‐Tseh Lin Breakdown of academic impact, for papers by Morten Mau‐Sørensen Breakdown of academic impact, for papers by Thierry Lesimple Breakdown of academic impact, for papers by Raoul Tibes Breakdown of academic impact, for papers by J. Thaddeus Beck Breakdown of academic impact, for papers by Tahseen Al‐Saleem Breakdown of academic impact, for papers by J Garcı́a-Conde
Rankless by CCL
2026